Loading...
Loading...
All product recalls associated with GENESIS.
Total Recalls
1000
Past Year
423
Class I (Serious)
54
Most Recent
Jan 2026
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
Hyundai Motor America (Hyundai) is recalling certain 2015-2016 Genesis and 2017-2020 Genesis G80 vehicles. The Anti-Lock Brake System (ABS) module could malfunction and short circuit.
Hyundai Motor America (Hyundai) is recalling certain 2019-2021 Genesis G70 vehicles. The Anti-Lock Brake System (ABS) module could malfunction and short circuit.
CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.
CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.
CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.
Vitamin D3 stability sample analyzed and found to be less than 100% of label claim.
Vitamin D3 stability sample analyzed and found to be less than 100% of label claim.
Volkswagen Group of America, Inc. (Volkswagen) is recalling certain 2018-2019 Atlas vehicles equipped with Continental tires. On the affected vehicles, it is possible that one or more tires were cured for too long during tire production.
Patient related messages created in RayCare 3B, RayCare 4A will be lost when upgrading from RayCare 2 to RayCare 3B or later
Volkswagen Group of America, Inc. (Volkswagen) is recalling certain 2021 Atlas and Atlas Cross Sport vehicles. The lug bolt holes on the wheels may have been machined incorrectly, preventing the wheel bolt from sufficiently attaching to the wheel bearing hub.
In case of a failed automatic marker detection, a software error causes parts of the display to incorrectly behave as if the current patient position is within predefined tolerances and may allow the user to proceed to treatment despite potentially exceeding shift values.
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
For some LINAC types, merging clinical beams with beams of approximate dose may lead to the approximate dose erroneously labeled as clinical dose. Merge beams can be used manually, in scripting, or as part of the Automated breast planning feature. In some cases, when merging two beams where the first beam has clinical dose and the second beam has approximate dose, the dose of the resulting beam will be labeled as Clinical, although dose for some of the beam segments is still calculated with the SVD dose engine and it should be labeled Approximate: Mixed dose. The difference between approximate and final Clinical dose is in most cases small, but there can be body sites such as lung where the difference can be significant.
Undeclared Red #40
Customers are being notified of results from a Toxicological Risk Assessment related to potential for aluminum ions to leach into warmed fluids.
Lack of Assurance of Sterility
Temperature Abuse; labeled with the incorrect room temperature (15-25 ¿C) storage conditions rather than the correct refrigerated (2 - 8 ¿C) storage conditions
Continental Tire the Americas, LLC. (Continental Tire) is recalling certain Continental, General, and Barum brand tires sold as original or replacement equipment. The affected tires were cured for too long during production.
There is a potential for hydraulic leakage at the inclination function to occur resulting in an unintended Trendelenburg or anti-Trendelenburg movement of the table top depending on patient positioning which may lead to the patient having to be transferred to another OR table causing a delay in the procedure.
Potential undeclared allergens (wheat and tree nuts)